Bcl-2 regulates amplification of caspase activation by cytochrome c  by Cosulich, Sabina C. et al.
Brief Communication 147
Bcl-2 regulates amplification of caspase activation by
cytochrome c
Sabina C. Cosulich*†‡, Peter J. Savory*‡ and Paul R. Clarke*§
Caspases, a family of specific proteases, have central
roles in apoptosis [1]. Caspase activation in response to
diverse apoptotic stimuli involves the relocalisation of
cytochrome c from mitochondria to the cytoplasm where
it stimulates the proteolytic processing of caspase
precursors. Cytochrome c release is controlled by
members of the Bcl-2 family of apoptosis regulators
[2,3]. The anti-apoptotic members Bcl-2 and Bcl-xL may
also control caspase activation independently of
cytochrome c relocalisation or may inhibit a positive
feedback mechanism [4–7]. Here, we investigate the role
of Bcl-2 family proteins in the regulation of caspase
activation using a model cell-free system. We found that
Bcl-2 and Bcl-xL set a threshold in the amount of
cytochrome c required to activate caspases, even in
soluble extracts lacking mitochondria. Addition of dATP
(which stimulates the procaspase-processing factor
Apaf-1 [8,9]) overcame inhibition of caspase activation by
Bcl-2, but did not prevent the control of cytochrome c
release from mitochondria by Bcl-2. Cytochrome c
release was accelerated by active caspase-3 and this
positive feedback was negatively regulated by Bcl-2.
These results provide evidence for a mechanism to
amplify caspase activation that is suppressed at several
distinct steps by Bcl-2, even after cytochrome c is
released from mitochondria.
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Results and discussion
In a cell-free system of Xenopus egg extracts that reproduces
many aspects of apoptosis, cytochrome c release from mito-
chondria and activation of a caspase-3-like enzyme occur
spontaneously after prolonged incubation. Both cytochrome
c release and caspase activation are inhibited by the addi-
tion of Bcl-2 [2,10–14]. Previously it has been reported that
exogenous cytochrome c bypasses the inhibitory effect of
Bcl-2-containing cell lysate [2,13,14], suggesting that Bcl-2
only acts upstream of cytochrome c release in the mecha-
nism of caspase activation. In this study, we have re-exam-
ined this question using a more quantitative analysis.
We found that purified recombinant Bcl-2 (4 µM) was
indeed ineffective in blocking the acceleration of caspase
activation in response to the addition of high levels
(400 nM) of exogenous cytochrome c to low-speed super-
natants (LSS) of Xenopus egg extracts (which contain
membrane fractions including mitochondria). Bcl-2
delayed caspase activation that was accelerated by 200 nM
cytochrome c, however, and completely blocked caspase
activation in LSS containing 100 nM exogenous
cytochrome c (Figure 1a). In high-speed supernatants
(HSS) prepared from Xenopus LSS by centrifugation and
removal of mitochondria and other heavy membranes,
4 µM Bcl-2 was still able to inhibit caspase activation
induced by cytochrome c, completely blocking activation
in the presence of 100 nM cytochrome c and delaying acti-
vation at 200–400 nM cytochrome c (Figure 1b). This
shows that Bcl-2 can regulate caspase activation down-
stream of cytochrome c release and does not require asso-
ciation with mitochondria for this activity. The ratio of
cytochrome c to Bcl-2 was important: at 100 nM
cytochrome c there was a progressive inhibition of caspase
activation with increasing concentrations of Bcl-2. A
greater concentration of Bcl-2 was required to inhibit the
effect of 200 nM cytochrome c, whereas caspase activation
initiated by 500 nM cytochrome c was not blocked even
by high concentrations of Bcl-2 (Figure 1c). The level of
Bcl-2 therefore sets a threshold for the amount of
cytochrome c required to activate cytosolic caspases.
The related protein Bcl-xL also inhibited caspase activation
in response to cytochrome c in Xenopus HSS (Figure 1d),
indicating that it can function in a similar fashion to Bcl-2.
In contrast, BH3 domains from the pro-apoptotic proteins
Bax and Bak, which have been shown to promote
cytochrome c release and caspase activation in Xenopus LSS
[11], had no effect on caspase activation in the soluble
extracts and failed to overcome the inhibition of caspase
activation by Bcl-2 or Bcl-xL (data not shown). Regulation
of caspase activation by cytochrome c seems to be con-
served in humans, as Bcl-2 (Figure 1e) or Bcl-xL (data not
shown) inhibited caspase activation in a post-mitochondrial
supernatant derived from human HeLa cells. Bcl-2 blocks
caspase-3 activation in these extracts by inhibiting the
proteolytic processing of procaspase-3 [15].
Activation of mammalian caspase-3 by Apaf-1 is stimulated
by dATP in a reaction that requires cytochrome c and
caspase-9 [8,9,16]. In Xenopus LSS, 1 mM dATP produced
a dramatic acceleration of caspase activation, suggesting
that an Apaf-1-like factor is also involved (Figure 2a).
However, dATP had little or no effect on the timing of
cytochrome c release into the post-mitochondrial fraction.
Although dATP uncoupled caspase activation from wide-
spread cytochrome c release in this experiment, it remained
possible that low levels of cytochrome c were released into
the soluble fraction during incubation. Indeed, in Xenopus
HSS, dATP alone had no effect on caspase activity, but
produced a marked stimulation when added together with
20 or 50 nM cytochrome c (Figure 2c) — concentrations of
cytochrome c that failed to activate caspases when added
alone. When added at 100 nM or greater, cytochrome c acti-
vated caspases in HSS even without added dATP
(Figure 2c). At 20 nM cytochrome c, 4 µM Bcl-2 was effec-
tive at preventing caspase activation even in the presence
of dATP, while at 50–100 nM cytochrome c, the inhibitory
effect of Bcl-2 could be partially overcome by dATP. Bcl-2
failed to block caspase activation initiated by 200 nM
cytochrome c with or without dATP. These results indicate
that stimulation of a soluble Apaf-1-like factor by dATP
decreases a threshold in the amount of cytochrome c
required to overcome the block on caspase activation by
Bcl-2. However, dATP does not interfere with the ability of
Bcl-2 to control cytochrome c release (Figure 2b), suggest-
ing that these functions are separable. 
In Xenopus LSS, when the release of endogenous
cytochrome c from mitochondria was accelerated by the
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Bcl-2 and Bcl-xL regulate caspase activation induced by cytochrome c
(cyt c). Bcl-2 protein was added to the particular extract at the same
time as cytochrome c and samples taken at the times shown. In this
and subsequent experiments, caspase activity was assayed by
monitoring the cleavage of the fluorogenic caspase substrate Ac-
DEVD–AMC. (a) Whole Xenopus egg extract containing mitochondria
(LSS). (b,c) Post-mitochondrial supernatant of Xenopus egg extracts
(HSS). In (a,b), Bcl-2 was added at 4 µM and incubations carried out
for the times shown; in (c), Bcl-2 was added at the concentrations
shown and incubations carried out for 15 min. (d) The Bcl-2-related
protein Bcl-xL (4 µM) also inhibits caspase activation induced by
cytochrome c in Xenopus HSS. (e) Post-mitochondrial (S100) extract
of HeLa cells. Bcl-2 was added at 8 µM. Each panel is representative
of at least three similar experiments.
addition of the BH3 domain of Bak (Figure 3a; see also
[11]), neither Ac-DEVD-CHO — a potent inhibitor of
caspase-3 — nor the more general caspase inhibitor
zVAD-fmk (data not shown) had any significant effect on
the extent of cytochrome c release. Although this result
does not exclude the possible involvement of a caspase
that was not blocked by these inhibitors, it is consistent
with previous evidence for a caspase-independent mecha-
nism for cytochrome c release triggered by Bak and some
other pro-apoptotic signals [2,4,13,14]. Ac-DEVD-CHO
was effective in inhibiting the spontaneous release of
cytochrome c, however, showing that caspase-3 or a similar
activity plays a role in the release of cytochrome c under
these conditions (Figure 3b). Furthermore, addition of
purified active caspase-3 to the extracts accelerated the
release of cytochrome c in a dose-dependent manner
(Figure 3c). When very high levels of caspase-3 were
added to egg extracts, Bcl-2 protein failed to prevent
cytochrome c release (data not shown). If a lower concen-
tration of caspase-3 was used (10 µg/ml), which is similar
in activity to that generated by activation of endogenous
caspases and still sufficient to markedly accelerate
cytochrome c release, 4 µM Bcl-2 was able to inhibit the
process completely, however (Figure 3c). Together, these
results suggest that that the widespread release of
cytochrome c from mitochondria is part of a mechanism
for the feedback amplification of caspase activity that is
under the control of Bcl-2.
In response to pro-apoptotic signals acting via mitochon-
dria, caspase-3 may be activated initially by caspase-9 in a
reaction dependent on cytochrome c and Apaf-1 [16].
Active caspase-3 would promote the widespread release of
cytochrome c and amplification of the signal, presumably
by cleaving regulatory protein(s). The amplification of
caspase activation must be tightly controlled to prevent
inappropriate apoptosis while allowing an effective
response to pro-apoptotic stimuli. In addition to its role in
controlling cytochrome c release from mitochondria, Bcl-2
sets a threshold in the amount of soluble cytochrome c
required for caspase activation, possibly by sequestering
cytochrome c in an inactive complex with Apaf-1 [17].
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Addition of dATP stimulates caspase activation in Xenopus egg
extracts. (a) Effects of dATP (1 mM) on caspase activation in Xenopus
LSS; caspase activation was accelerated by dATP even in the presence
of Bcl-2. (b) Levels of cytochrome c released from the LSS into the
HSS under the indicated conditions as detected by western blotting:
dATP thus accelerates caspase activation even when Bcl-2 prevents
widespread release of cytochrome c into the post-mitochondrial
supernatant. Cytochrome c was detected on western blots using a
specific anti-cytochrome c antibody (Pharmingen) [11]. (c) Cytochrome
c is required for dATP (1 mM) to stimulate caspase activation in
Xenopus HSS, and dATP decreases the concentration of cytochrome c
required to overcome inhibition of caspase activation by Bcl-2. In (c),
cytochrome c was added at the concentration shown in each panel and
Bcl-2 was added at 4 µM.
This threshold effect, together with control of the feed-
back amplification of cytochrome c release promoted by
active caspases (this study and [18]), provides for a
dynamic process in which Bcl-2 acts at several steps to
determine the response to pro-apoptotic signals initiating
at mitochondria or elsewhere. The release of cytochrome c
from mitochondria to a sub-threshold level and partial
caspase activation would not necessarily lead to cell death.
Once the threshold is exceeded, however, widespread
caspase activation and apoptosis would ensue.
Materials and methods
Preparation of extracts and recombinant proteins
Xenopus egg extracts containing cycloheximide, cytochalasin B and an
ATP-regenerating system were prepared as described previously [12].
HSS extracts were prepared by centrifugation of the LSS extracts at
100,000 × g. HeLa S100 extracts were prepared as described previ-
ously [19]. Caspase-3 was produced by expressing the p12 and p17
subunits separately in Escherichia. coli BL21 DE3. Active enzyme gen-
erated by mixing stoichiometric amounts of the subunits was stored in
PBS at –70°C. Bcl-2, Bcl-xL (both tagged at the amino terminus with a
His6 tag) and GST—Bak-BH3 were expressed in E. coli BL21 DE3 as
described previously [11,19]. Horse cytochrome c was purchased
from Sigma.
Caspase assays
Samples (2 µl) of each pre-incubation mixture were diluted 50-fold into
100 µl extraction buffer [11] containing 50 mM Ac-DEVD–AMC (Cal-
biochem), prewarmed to 23°C, then incubated at 23°C for 10 min,
before stopping by addition of sodium acetate buffer which reduces the
pH to 4.5. All assays were carried out in duplicate and read after dilution
with 2 ml water in a Perkin–Elmer LS-5B fluorimeter using an excitation
wavelength of 380 nm and an emission wavelength of 460 nm. Assays
were carried in a 0.1 ml microcuvette thermostatted to 23°C and moni-
tored in real time to determine that AMC release was linear with time.
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Figure 3
Release of cytochrome c from LSS of Xenopus egg extracts into the
post-mitochondrial supernatant (HSS), following incubation with the
indicated factors, as detected by western blot analysis of HSS. (a) Effect
of 0.1 mg/ml Bak-BH3 domain on cytochrome c release in the presence
or absence of 1 µM Ac-DEVD-CHO (DEVD). (b) Effect of Ac-DEVD-
CHO on spontaneous cytochrome c release. (c) Effect of 4 µM Bcl-2 on
cytochrome c release accelerated by increasing amounts of caspase-3. 
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